Smaller brain size likely in young adults (<40 years old) with depressive symptoms compared to healthy controls: a retrospective study.
OBJECTIVE
The aim of this study was to determine whether the brain size of young patients with depressive symptoms is smaller than that of healthy controls using magnetic resonance imaging (MRI).


METHODS
We retrospectively evaluated brain size by calculating the ratio of the brain area to that of the skull (the brain-to-skull ratio) on routine MRI scans including the splenium of the corpus callosum obtained from 19 patients <40 years old with depressive symptoms in 2009. The controls were 12 healthy individuals <40 years old who underwent MRI for medical examinations.


RESULTS
The mean brain-to-skull ratio of the control group was 0.850 ± 0.022 (range 0.822-0.889), and that of the patient group was 0.819 ± 0.041 (range 0.756-0.878). An unpaired t-test showed a significant difference in the brain-to-skull ratios between these groups (P = 0.011). In particular, in 7 of the 19 patients with longer duration of illness and more severe symptoms, the brainto-skull ratio was 89%-92% of the mean ratio of the control group.


CONCLUSIONS
The brain size of young patients with depressive symptoms appears to be smaller than that of healthy controls.
Department of Radiology, Ohshima Clinic, Yamagata, 990-2321, Japan. miadchi@beach.ocn.ne.jp
Michito
M
Adachi
Akiko
A
Shibata
Takamichi
T
Sato
Etsuko
E
Kawaguchi
D000328:Adult; D001921:Brain / Q000473:pathology*; D016022:Case-Control Studies; D003337:Corpus Callosum / Q000473:pathology; D003866:Depressive Disorder / Q000473:pathology*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D012189:Retrospective Studies
J Alzheimers Dis. 2009;18(1):11-30
19542627
AJNR Am J Neuroradiol. 1997 Feb;18(2):367-78
9111678
Lancet. 2009 Feb 7;373(9662):492-501
19168210
Biol Psychiatry. 2006 Jun 15;59(12):1116-27
16631126
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Feb;27(1):85-102
12551730
J Psychiatry Neurosci. 2006 Sep;31(5):316-23
16951734
Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):365-70
19935145
Int Rev Psychiatry. 2004 Nov;16(4):260-83
16194760
J Neurol Sci. 2009 Mar 15;278(1-2):30-4
19059611
Arch Gen Psychiatry. 2008 Oct;65(10):1156-65
18838632
Drugs. 1986 Dec;32(6):481-508
2878798
Arch Neurol. 2008 Oct;65(10):1363-7
18852353
Am J Alzheimers Dis Other Demen. 2008 Aug-Sep;23(4):326-33
18453641
Neurology. 2000 May 9;54(9):1760-7
10802781
AJNR Am J Neuroradiol. 2003 Sep;24(8):1575-81
13679273
Neuroimage. 2000 Jun;11(6 Pt 1):805-21
10860804
J Affect Disord. 2010 Mar;121(3):231-8
19540599
J Psychiatr Res. 2007 Dec;41(12):979-90
17239400
Arch Gen Psychiatry. 2010 Mar;67(3):270-6
20194827
J Psychiatr Res. 2008 Oct;42(14):1145-53
18313696
Neurology. 2000 Aug 22;55(4):484-89
10953178
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1023-6
17433517
Minerva Pediatr. 2009 Jun;61(3):333-47
19461576
Stroke. 2004 Jan;35(1):16-21
14657449
Neuroreport. 2007 Sep 17;18(14):1511-4
17712285
Am J Geriatr Psychiatry. 2008 Dec;16(12):974-80
19038896
Int J Psychiatry Med. 1993;23(1):1-27
8514462
Psychosom Med. 2006 Sep-Oct;68(5):778-85
17012533
Neuropsychopharmacology. 2008 Dec;33(13):3157-63
18368034
AJNR Am J Neuroradiol. 2001 Oct;22(9):1680-5
11673161
Geriatrics. 1993 Dec;48(12):48-51
8253394
Am J Geriatr Psychiatry. 2008 Oct;16(10):834-43
18827230
J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):441-7
11561025